NM_000059.4(BRCA2):c.3437A>T (p.Glu1146Val) AND Hereditary breast ovarian cancer syndrome
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Dec 23, 2021
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001224564.4
Allele description [Variation Report for NM_000059.4(BRCA2):c.3437A>T (p.Glu1146Val)]
NM_000059.4(BRCA2):c.3437A>T (p.Glu1146Val)
Condition(s)
- Name:
- Hereditary breast ovarian cancer syndrome
- Synonyms:
- Hereditary breast and ovarian cancer syndrome; Hereditary breast and ovarian cancer; Hereditary breast and ovarian cancer syndrome (HBOC); See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0003582; MeSH: D061325; MedGen: C0677776; Orphanet: 145
-
COA5[gene] (43)
ClinVar
-
Smooth muscle cell cord morphogenesis (HG-U133A)
Smooth muscle cell cord morphogenesis (HG-U133A)Accession: GDS3852GDSBrowser
-
(GDS3852[ACCN]) AND GDS[filter] (1)
GDSBrowser
-
REFERENCES - Toxicological Profile for Atrazine
REFERENCES - Toxicological Profile for Atrazine
-
PmeII family type II restriction endonuclease [Clostridioides difficile]
PmeII family type II restriction endonuclease [Clostridioides difficile]gi|544970833|ref|WP_021373710.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 1, 2024